Research Library

Fellow Katharine Neill Harris considers the validity of risk assessment tools, which estimate the likelihood that an individual who has been charged with or convicted of a crime will commit a future offense. Baker Institute Blog: https://bit.ly/2Cwl6jc

Despite internal changes in how scientists are nominated for the Nobel Prize, there is still a substantial gender bias in prize recipients. Concrete policy changes are needed to ensure more diversity is reflected in the world’s most visible and prestigious scientific honor, write experts Kenneth M. Evans, Kirstin R.W. Matthews and Daniel Moralí. Baker Institute blog: http://bit.ly/2MDRDbW

Body-worn cameras (BWCs) are becoming a permanent fixture of modern policing, and their effects are likely to be much more nuanced than originally predicted.

The author reviews four scenarios that could develop as the dispute over Turkey's purchase of a Russian-made missile defense system continues.

Despite the wealth of evidence attesting to the efficacy of medication-assisted treatment for opioid addiction, the majority of Americans who need it can't get it — including in Harris County, Texas’ largest county. Baker Institute Blog: https://bit.ly/31D9qGV

Gene editing in humans raises ethical and safety issues that require further discussion to identify a responsible way forward.

According to the authors, developments in cannabis law, arbitration clause interpretation and the economic loss doctrine show that numerous facets of business litigation are changing rapidly.

In recent years public opinion surveys have found that a consistent and increasing percentage of Texans support marijuana reform, but this support has not translated into policy change. The authors explain why it should.

By providing regulated and safe access to medical cannabis to people with demonstrated need, the Texas Legislature can provide justified relief, help reduce the opioid epidemic, and save Texas millions of dollars, write the authors.

The recent rise in opioid-related overdose deaths is part of a larger trend in drug use that started over 40 years ago, writes Katharine Neill Harris, the Alfred C. Glassell, III, Fellow in Drug Policy.